ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
-1.03%
US Dollar vs AUD
1.5147
-0.47%
Bitcoin
62,464.35
5.65%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Inovio Pharmaceuticals Inc New (INO)

  7. Inovio Pharmaceuticals Inc New (INO) News

INO

Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals Inc New
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INO
DateTimeSourceHeadlineSymbolCompany
01/05/202422:00PR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
29/04/202422:00PR Newswire (US)INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024NASDAQ:INOInovio Pharmaceuticals Inc New
29/04/202422:00PR Newswire (US)INOVIO to Participate in Upcoming Investor Conferences in MayNASDAQ:INOInovio Pharmaceuticals Inc New
16/04/202408:39PR Newswire (US)INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsNASDAQ:INOInovio Pharmaceuticals Inc New
27/03/202409:28PR Newswire (US)INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn MedicineNASDAQ:INOInovio Pharmaceuticals Inc New
07/03/202408:05PR Newswire (US)INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:INOInovio Pharmaceuticals Inc New
06/03/202423:00PR Newswire (US)Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:INOInovio Pharmaceuticals Inc New
06/03/202422:02IH Market NewsU.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices ClimbNASDAQ:INOInovio Pharmaceuticals Inc New
22/02/202400:00PR Newswire (US)INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024NASDAQ:INOInovio Pharmaceuticals Inc New
08/02/202403:46PR Newswire (US)INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:INOInovio Pharmaceuticals Inc New
03/02/202400:00PR Newswire (US)INOVIO Reports Inducement Grant Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
01/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INOInovio Pharmaceuticals Inc New
27/01/202408:01Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:INOInovio Pharmaceuticals Inc New
26/01/202408:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
24/01/202400:00PR Newswire (US)INOVIO Announces Effective Date of 1-for-12 Reverse Stock SplitNASDAQ:INOInovio Pharmaceuticals Inc New
23/01/202400:00PR Newswire (US)INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion LeaderNASDAQ:INOInovio Pharmaceuticals Inc New
13/01/202409:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
05/01/202400:00PR Newswire (US)INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)NASDAQ:INOInovio Pharmaceuticals Inc New
04/01/202400:00PR Newswire (US)INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval ProgramNASDAQ:INOInovio Pharmaceuticals Inc New
29/11/202308:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INOInovio Pharmaceuticals Inc New
18/11/202308:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:INOInovio Pharmaceuticals Inc New
10/11/202308:35Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INOInovio Pharmaceuticals Inc New
10/11/202308:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
10/11/202308:05PR Newswire (US)INOVIO Reports Third Quarter 2023 Financial Results and Operational HighlightsNASDAQ:INOInovio Pharmaceuticals Inc New
10/11/202308:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INOInovio Pharmaceuticals Inc New
03/11/202307:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
01/11/202323:00PR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
26/10/202323:00PR Newswire (US)INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023NASDAQ:INOInovio Pharmaceuticals Inc New
11/10/202307:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
11/10/202301:51Dow Jones NewsInovio Shares Rise 8% After FDA Feedback for INO-3107NASDAQ:INOInovio Pharmaceuticals Inc New
 Showing the most relevant articles for your search:NASDAQ:INO

Your Recent History

ASX
SUN
Suncorp
ASX
WPL
Woodside Petroleum
NYSE
KO
Coca Cola
FX
AUDCAD
AUD vs CAD
ASX
QBE
QBE Insurance
ASX
MQG
Macquarie
ASX
RIO
Rio Tinto
ASX
WDC
Westfield
FTSE
UKX
FTSE 100
CCOM
SILVER
SILVER
FX
AUDUSD
AUD vs US Dollar
ASX
WOW
Woolworths
SPI
SP500
S&P 500
NASDAQ
AAPL
Apple
ASX
XFL
S&P ASX 50
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved